Industry Insights

Future CRM systems need to integrate more aspects of the customer experience by orchestrating omnichannel engagement, capturing real-time insights, and supporting personalized, compliant interactions across the customer journey.

A Center of Excellence (CoE) is no longer a “nice to have”, it’s the operating model that keeps Veeva programs sustainable and scalable.

You can’t build a next-gen pharma company on a shaky foundation. Here’s what it really takes to get AI-ready and why the backbone of your data systems, not your algorithms, is the place to start.

Approval is approaching, and excitement builds across the organization. Years of research and regulatory work have led to this point, but as the finish line nears, a familiar question surfaces: are we truly ready to go live?

It usually starts with the right intentions. A pre-commercial pharma team is preparing for launch: scoping out field operations, making CRM decisions, and beginning to think about analytics. Everyone is focused on execution. But beneath all of that activity, one critical question gets overlooked: Is your data infrastructure ready to support what’s coming?

What if your CRM could drive smarter, more connected HCP engagement? It starts by rethinking CRM as a Customer Experience Management (CxM) platform—not just a system of record.

For pharma Sales Ops and IT leaders, the biggest drain on ROI isn’t the technology itself — it’s how effectively the field learns to use it.

The email usually arrives on a Monday morning, bringing yet another urgent RFP, a dozen stakeholders, and no time to spare. You pull together what you can, gathering input from R&D, legal, and commercial teams, each requiring additional information.